As a result of the Company's efforts, the U.S. patent and trademark office (PTO) declared a patent interference on May 3, 2013, between issued U.S. Patent number 8,195,415, which is asserted against the Company in litigation, and U.S. patent application number 13/070,266, which is exclusively licensed to Sequenom, Inc. On the same date, the PTO also re-declared patent interference number 105,920, between issued U.S. Patent no. 8,008,018, which is also asserted against the Company in litigation, and U.S. patent application no. 13/070,275, which is exclusively licensed to Sequenom, Inc. On May 3, 2013, the PTO also declared two additional patent interferences (nos. 105,923 and 105,924) between patent applications licensed to another party and patent applications licensed to Sequenom, Inc.
"We are encouraged by these decisions by the PTO and look forward to continued developments in this important area," said Bill Bowen , Senior Vice President and General Counsel of Sequenom, Inc.
Conference Call Information
A conference call hosted by Harry F. Hixson, Jr. , Ph.D., Chairman and CEO, and other members of senior management will take place today, May 9, at 5:00 pm ET (2:00 pm PT) and will be webcast live on the Sequenom website. To access the live teleconference call, dial 800-860-2442 in the U.S. and 412-858-4600 for international callers. Please specify to the operator that you would like to join the "Sequenom First Quarter 2013 Earnings Conference Call." If you are unable to listen to the live webcast, a teleconference replay will be available until Thursday, May 16, 2013. Interested parties can access the replay by dialing 877-344-7529 or 412-317-0088 internationally and entering the conference number 10028207.
|SOURCE Sequenom, Inc.|
Copyright©2012 PR Newswire.
All rights reserved